Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Protogene and Silicon Genetics Agree to Co-Market Microarray Products

This article has been updated from a previous version.

N EW YORK, Jan 25 – In a combined effort to target microarrays users, Protogene Laboratories and Silicon Genetics have agreed to co-market Protogene's custom DNA microarrays and Silicon Genetics' GeneSpring microarray expression analysis software, the companies announced Thursday.

“We make complementary products—we both target the same customers,” said Peter Christey, vice president for business development at Protogene. The agreement paves the way for Protogene to make their chips compatible with GeneSpring, Christey added. “If [customers] buy Protogene chips they’ll be able to use Silicon Genetics software.”

Protogene’s microarray relies on in situ synthesis of oligonucleotides, inkjet printing, and its patented surface tension array technology. Oligonucleotide technology generates superior data compared to cDNA arrays, because oligonucleotides are prepared base by base, allowing greater specificity and control over the experiment, Christey said.

GeneSpring allows users to analyze both single genes and whole genomes using multiple parameters.

Protogene customers will benefit by having direct access to a mature, high-quality, desktop tool for analyzing their Protogene array data,” John Pietrzyk, Silicon Genetics' vice president for business development said in a statement.

In another agreement announced on Tuesday, Gene Logic announced that it would bundle GeneSpring along with its GeneExpress database suite.
The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.